Publications by authors named "Jean L Yan"

Claim this Profile
P
Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: A Phase 2a, Multicenter Prospective Trial.
John Bradley, Emmanuel Roilides, Margaret Tawadrous, Jean Li Yan, Elena Soto

J Pediatric Infect Dis Soc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancer.
Lisa R Hartman, Ildar Nurmeev, Pavel Svirin, Kevin D Wolter, Jean Li Yan

Pediatr Blood Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.
Matthew Dryden, Michal Kantecki, Jean Li Yan, Gregory G Stone, Heidi Leister-Tebbe

J Glob Antimicrob Resist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials.
Mark Wilcox, Jean Li Yan, Pedro L Gonzalez, Matthew Dryden, Gregory G Stone

Infect Dis Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial.
Chao Zhuo, Yijiang Huang, Wenyuan Liu, Jin-Fu Xu, Wei Yun Zhu, Jean Li Yan

Infect Drug Resist· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies.
Francesco Giuseppe De Rosa, Alessandro Busca, Maria Rita Capparella, Jean Li Yan, Jalal A Aram

Clin Drug Investig· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics and Outcomes Among Patients with Complicated Skin and Soft Tissue Infections Admitted to the Intensive Care Unit: Analysis of the Phase 3 COVERS Randomized Trial of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam.
Miguel Sánchez-García, Jennifer Hammond, Jean Li Yan, Michal Kantecki, Wajeeha Ansari

Infect Dis Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis.
John S Bradley, Gregory G Stone, Phylinda L S Chan, Susan R Raber, Todd Riccobene, Jean Li Yan

Pediatr Infect Dis J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia.
Emmanuel Roilides, Fabianne Carlesse, Margaret Tawadrous, Heidi Leister-Tebbe, Umberto Conte, Jean L Yan

Pediatr Infect Dis J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.
Gabriele Sganga, Minggui Wang, M Rita Capparella, Margaret Tawadrous, Jean L Yan

Eur J Clin Microbiol Infect Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
Dong-Gun Lee, Hye-Jung Lee, Jean Li Yan, Stephen Sheng-Fong Lin, Jalal A Aram

Mycoses· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
Jie Jin, Depei Wu, Yang Liu, Sisi Pan, Jean Li Yan

BMC Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h.
Karen Cheng, Rienk Pypstra, Jean Li Yan, Jennifer Hammond

J Antimicrob Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age.
Emmanuel Roilides, Fabianne Carlesse, Heidi Leister-Tebbe, Umberto Conte, Jean L Yan

Pediatr Infect Dis J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
Shampa Das, Jianguo Li, Joseph Iaconis, Diansong Zhou, Gregory G Stone, Jean Li Yan

J Antimicrob Chemother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.
Dimitrios P Kontoyiannis, Matteo Bassetti, Marcio Nucci, Maria Rita Capparella, Jean L Yan

Mycoses· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.
Bart Jan Kullberg, José Vasquez, Piroon Mootsikapun, Marcio Nucci, José-Artur Paiva, Jean Li Yan

J Antimicrob Chemother· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis.
Judith M Martin, Mercedes Macias-Parra, Peter Mudry, Umberto Conte, Jean L Yan

Pediatr Infect Dis J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials.
Matteo Bassetti, Paul C McGovern, Christoph Wenisch, R Daniel Meyer, Jean Li Yan

Int J Antimicrob Agents· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.
Julio Ramirez, Nathalie Dartois, Hassan Gandjini, Jean Li Yan, Joan Korth-Bradley

Antimicrob Agents Chemother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.
Jay Purdy, Sylvie Jouve, Jean Li Yan, Ivana Balter, Nathalie Dartois

Clin Ther· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis